AzTrials
AzTrials

Surgical Procedure, UnspecifiedPACMANNCT06148701

Preoperative Anesthesia Automatic System:a Retrospective Cohort Study

An observational study of Surgical Procedure, Unspecified and Anesthesia, run by Jeroen Bosch Ziekenhuis at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To evaluate of PACMAN triage system is able to discern patient who may be safely screened by phone Read more about this study

Who is it for?
Ages 18 years and older
How many people
1,019 participants
Where
1 siteNetherlands
Study dates
1 Oct 2021to 1 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients scheduled for all kind of surgical procedures except cardiac surgery and intracranial surgery

Who may be able to join

  • >18 years old, scheduled for elective clinical interventions under procedural sedation and all types of elective medium or low risk surgery with anaesthetic guidance, as defined by the European Society of Anaesthesia (ESA) guidelines.

Who cannot join

  • <18 years. Patients scheduled for emergency and high-risk surgery were excluded as the policy of our department dictates that these patients must always be seen in person, according to ESA guidelines.

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, North Brabant, 5200 ME

Other trials in Netherlands

About this study

Official title: The Preoperative Anesthesia automatiC systeM for triAge and screeNing (PACMAN) as a Model for Recognition of Patients Who May Screened by Phone: a Retrospective Cohort Study

To evaluate of PACMAN triage system is able to discern patient who may be safely screened by phone

Read the detailed description

PACMAN triage system consists of a health questionnaire and an algorithm. Patient were called up by registered nurses and asked to answer the questionnaire. Patients answers were applied to PACMAN algorithm to determine what kind of screening patient should receive: in person or by phone.

Keywords
Anaesthetists / Health Care Surveys / Preoperative Care / Triage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduction of the number of in person consultations

    In 2019 all patients were screened in person. Aim of the study is to evaluate whether implementation of PACMAN leads to a significant reduction of the number of in person consultations

    Measured: between start inclusion and 6 months after start inclusion

Secondary outcomes (3)
  1. Reliability of PACMAN

    Reliability of the triage procedure was evaluated by verifying the PACMAN outcome (PhC vs in-PC) against the assigned ASA-PS classification. Patients scheduled for a PhC were considered to be accurately triaged if classified ASA-PS I-II or III with stable comorbidities. Patients scheduled for an in-PC were considered to be accurately triaged if classified ASA-PS III with unstable comorbidities or IV.

    Measured: between start inclusion and 6 months after start inclusion

  2. Patients outcome

    To measure the impact of PACMAN on patient outcomes we evaluated the occurrence of perioperative unanticipated adverse events (UAE). An anaesthesia-related UAE was defined as an event causing mortality or morbidity, occurring during the perioperative period or up to seven days after surgery and requiring special medical treatment or prolongation of hospitalisation beyond the expected length of stay. Data concerning perioperative UAE were collected by reviewing the EMR of patients who had undergone surgery.

    Measured: between start inclusion and 6 months after start inclusion

  3. Cost-effectiveness

    we examined cost-effectiveness and efficiency by determining the time taken by screening staff for a single PhC or in-PC and the average number of patients screened before and after implementation of PACMAN along with related staff costs.

    Measured: between start inclusion and 6 months after start inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Nov 2023
  2. Study start1 Oct 2021
  3. Primary completion1 Nov 2021
  4. Study completion1 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,019 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06148701
Sponsor's protocol ID
2021.08.06.01
Acronym
PACMAN
Status last verified
Nov 2023
First submitted
20 Nov 2023
Last updated
28 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Di Biase M, van der Zwaard B, Aarts F, Pieters B. Pre-operative triAge proCedure to streaMline elective surgicAl patieNts (PACMAN) improves efficiency by selecting patients eligible for phone consultation: A retrospective cohort study. Eur J Anaesthesiol. 2024 Nov 1;41(11):813-820. doi: 10.1097/EJA.0000000000002055. Epub 2024 Sep 9.

    PubMed 39252617

Questions about this trial

What is this clinical trial studying?

An observational study of Surgical Procedure, Unspecified and Anesthesia, run by Jeroen Bosch Ziekenhuis at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduction of the number of in person consultations (time frame: between start inclusion and 6 months after start inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06148701, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in